Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853
Beginning balance	$ (1,153,632)	$ (1,034,012)
Net loss	$ (26,344)	(24,667)
Ending balance (in shares)	1,233,853
Ending balance	$ (1,179,976)	$ (1,058,679)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323
Ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,236,188)	(1,116,568)
Net loss	(26,344)	(24,667)
Ending balance	$ (1,262,532)	$ (1,141,235)